本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

GeneDx Holdings

130.66
+1.791.39%
盘后138.007.34+5.62%19:43 EDT
成交量:86.73万
成交额:1.13亿
市值:37.53亿
市盈率:2,696.08
高:133.72
开:129.20
低:126.44
收:128.87
52周最高:136.00
52周最低:55.17
股本:2,872.62万
流通股本:1,994.49万
量比:2.15
换手率:4.35%
股息:- -
股息率:- -
每股收益(TTM):0.0485
每股收益(LYR):-1.9444
净资产收益率:0.60%
总资产收益率:1.05%
市净率:13.54
市盈率(LYR):-67.20

数据加载中...

2025/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/20

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/02/20

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/02/20

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/02/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/18

重要事件披露

Form 8-K - Current report
2025/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities